AGA Medical Reaches Settlement With Justice Dept. Over Bribes In China
This article was originally published in The Gray Sheet
Executive Summary
AGA Medical, a private firm that makes patent foramen ovale closure devices, agreed June 3 to immediately pay a $2 million criminal penalty under the Foreign Corrupt Practices Act (FCPA) and enter into a deferred prosecution agreement with the Department of Justice in connection with payments the company made to doctors in China
You may also be interested in...
SEC, DoJ Beef Up Investigation Of Corporate Bribery And Corruption Overseas
Device and pharmaceutical companies have been battered by government and congressional investigations of their domestic marketing practices. They now face increased scrutiny on another front as the Department of Justice and the Securities and Exchange Commission are stepping up their investigation of corporate corruption and bribery abroad
SEC, DoJ Beef Up Investigation Of Corporate Bribery And Corruption Overseas
Device and pharmaceutical companies have been battered by government and congressional investigations of their domestic marketing practices. They now face increased scrutiny on another front as the Department of Justice and the Securities and Exchange Commission are stepping up their investigation of corporate corruption and bribery abroad
Anti-Corruption Regs In China Should Be Warning Sign For Companies
The Chinese government's focus on corruption means device companies doing business there must redouble compliance efforts, says Australia medical device lobbyist Anne Trimmer